Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05322239 · ClinicalTrials.gov registry record · NA
Resting State Changes Following Theta Burst Stimulation
A NA study of Brain Connectivity, sponsored by Nicholas Balderston, PhD.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05322239 is a NA study of Brain Connectivity that is actively recruiting participants, run by Nicholas Balderston, PhD. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05322239, a NA study of Brain Connectivity, is actively recruiting participants, sponsored by Nicholas Balderston, PhD.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Transcranial magnetic stimulation (TMS) is increasingly being applied to effectively treat mental illness, however efforts to quantify the effects of TMS on the network architecture of the brain have largely been limited in scope and tied to specific neurologic and psychiatric disorders. The objective of the current work is to build and validate a whole-brain, domain-general model of brain connectivity changes following TMS, based on physical models of the current distribution at the cortex. PUBLIC HEALTH RELEVANCE: This work is relevant to public health because it will provide direct evidence that brain connectivity changes following neuromodulatory TMS vary as a function of the current density at the cortex, which can be used to predict psychiatric symptom change following neuromodulatory TMS.
Conditions Studied
Interventions
- DEVICE Intermittent Theta Burst Stimulation
- DEVICE Continuous Theta Burst Stimulation
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-11-17 |
| Est. Completion | 2027-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05322239
The ClinicalTrials.gov registry entry for NCT05322239 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nicholas Balderston, PhD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Brain Connectivity appearing as the primary indexed condition, and to 2 interventions - of which Intermittent Theta Burst Stimulation is the first listed.
NCT05322239 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05322239 about?
NCT05322239 is a clinical study titled "Resting State Changes Following Theta Burst Stimulation". Transcranial magnetic stimulation (TMS) is increasingly being applied to effectively treat mental illness, however efforts to quantify the effects of TMS on the network architecture of the brain have largely been limited in scope and tied to specific neurologic and psychiatric disorders. The objecti...
What is the current status of trial NCT05322239?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2022-11-17. Estimated completion is 2027-08-01.
What conditions does trial NCT05322239 study?
This clinical trial studies the following conditions: Brain Connectivity.
What interventions are being tested in trial NCT05322239?
The interventions under investigation include: Intermittent Theta Burst Stimulation (DEVICE), Continuous Theta Burst Stimulation (DEVICE).
Who is sponsoring clinical trial NCT05322239?
This trial is sponsored by Nicholas Balderston, PhD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05322239 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.